Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy. Clin Cardiol 2023 Oct;46(10):1297-1298

Date

08/22/2023

Pubmed ID

37605641

Pubmed Central ID

PMC10577569

DOI

10.1002/clc.24138

Scopus ID

2-s2.0-85168464826 (requires institutional sign-in at Scopus site)

Abstract

Our previous study aimed to investigate overall survival (OS) and sudden cardiac death (SCD) variables in nonischemic dilated cardiomyopathy (DCM) patients treated only with standard medical treatments versus those who received implantable cardioverter defibrillator (ICD) in addition to routine medical treatments. Our findings revealed no significant difference in OS between the two groups (pā€‰=ā€‰.25), but a significant decrease in SCD rate due to ICD insertion (pā€‰=ā€‰.02). Furthermore, we found no significant difference between the two groups concerning baseline characteristics and type of medical treatments received. We attempted to answer and clarify the concerning points regarding the survival benefits of ICD insertion in nonischemic DCM patients that were mentioned.

Author List

Salehi Omran H, Irilouzadian R, Hedayati Goudarzi MT, Salehi Omran MT

Author

Hossein Salehi Omran MD Postdoctoral Researcher in the Cell Biology, Neurobiology and Anatomy department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Cardiomyopathy, Dilated
Death, Sudden, Cardiac
Defibrillators, Implantable
Humans
Risk Factors